Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Carnitine × Clear all

Phase

Status

Sponsor Class

OTHER 9 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Cisplatin 39 Capecitabine 34 Gemcitabine 28 Paclitaxel 27 Carboplatin 27 apatinib 26 Radiotherapy 26 Oxaliplatin 25 Drug Therapy 25 Docetaxel 25 Cyclophosphamide 25 Irinotecan 24 tislelizumab 23 Fluorouracil 21 Bevacizumab 21 Nivolumab 16 pembrolizumab 15 Exercise 15 fludarabine 14 Surgical Procedures, Operative 14 camrelizumab 13 S 1 (combination) 13 Metformin 13 Radiation 12 Pemetrexed 10 Control Groups 10 Vinorelbine 9 Standard of Care 9 Leucovorin 9 Letrozole 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04672720 2023-06-18

L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

Royan Institute

Phase NA Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡